Recalls & Warnings February 06, 2023 FDA Warns Companies Promoting Products to Treat Monkeypox, COVID-19, & Other Viruses On January 30, 2023, the FDA issued a warning letter to four companies following review of the company websites, which found statements about company products to be drug claims because they were promoted to mitigate, prevent, treat, diagnose, or cure viruses such as monkeypox
doi: 10.1016/j.freeradbiomed.2015.05.013 123 LiuHXieJFanLXiaYPengXZhouJet al
ACHIEVE-1 was a 40-week, randomized, double-blind, placebo-controlled trial comparing the efficacy and safety of orforglipron 3 mg, 12 mg, and 36 mg vs
For people with diabetes, it is important to note that ACV can interact with some medications, including insulin